Shenzhen, Guangdong, China Related Funds
| Fund Name | Location |
| Alphemy Capital fund | - |
| BioInnovation | Cambridge, Massachusetts, United States |
| Bridge Boys | Boston, Massachusetts, United States |
| Chase Manhattan Corporation | Manhattan, New York, United States |
| CHUGIN LEASE | Japan, Okayama, Okayama Prefecture |
| Hargreave Hale Aim VCT | England, London, United Kingdom |
| Heron Capital | Carmel, Indiana, United States |
| Implistic Capital | Las Vegas, Nevada, United States |
| Jackson Square Ventures | California, San Francisco, United States |
| Lanying Materials Trade | China, Jiangsu, Suzhou |
| Medical Incubator Japan | - |
| NL Ventures | Chicago, Illinois, United States |
| Novo Nordisk Foundation | Capital Region of Denmark, Denmark, Hovedstaden |
| Pidilite Industries Limited | India, Maharashtra, Mumbai |
| SBI Investment Korea | Seoul, Seoul-t'ukpyolsi, South Korea |
| Shanghai Qianyi Investment Management | China, Shanghai |
| Spring Capital | Estonia, Harjumaa, Tallinn |
| Underdog Ventures | Island Pond, United States, Vermont |
| UVM 2 Venture Investments | Central, Central Region, Singapore |
| zipdragon ventures | California, San Francisco, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
OO Eye Instrument | $2M | 25 Sep 2019 | Beijing | ||
Timekettle | $1M | 29 Aug 2019 | Shenzhen, Guangdong, China | ||
| $1M | 14 Sep 2018 | China, Beijing | |||
Geneinno | $2M | 31 Jan 2018 | China, Hunan, China | ||
Liequ | $15M | 13 Feb 2017 | China, " China"} | ||
Acen Med | $463K | 22 Nov 2016 | Pingshan District, Guangdong Province, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
OO Eye Instrument | $2M | 25 Sep 2019 | Beijing | ||
Timekettle | $1M | 29 Aug 2019 | Shenzhen, Guangdong, China | ||
| $1M | 14 Sep 2018 | China, Beijing | |||
Geneinno | $2M | 31 Jan 2018 | China, Hunan, China | ||
Liequ | $15M | 13 Feb 2017 | China, " China"} | ||
Acen Med | $463K | 22 Nov 2016 | Pingshan District, Guangdong Province, China |
